Cite

HARVARD Citation

    McAllister-Williams, R. et al. (2016). Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial. Lancet. pp. 117-127. [Online]. 
  
Back to record